A boost in microRNA may protect against sepsis and other inflammatory diseases

Acute inflammatory diseases, such as sepsis, as well as chronic inflammatory diseases like diabetes and arthritis, develop as a result of sustained inflammation of the blood vessel wall. Researchers at Brigham and Women's Hospital (BWH) have discovered that a microRNA (small, non-coding RNA molecule) called miR-181b can reduce the inflammatory response that is responsible for such diseases.

The findings, by researchers led by Mark Feinberg, MD from BWH and Harvard Medical School, will pave the way for new targets in the development of anti-inflammatory therapies.

The study is published in the May 24, 2012 online edition of The .

The researchers identified that expression of miR-181b was reduced in both mice and critically ill patients with sepsis. Sepsis is a devastating whole-body due to infection and is associated with reduced survival.

Each one unit increase in microRNA-181b was associated with a decrease in the odds of having sepsis, suggesting that higher levels of miR-181b may be protective.

The inflammatory response (such as that which causes sepsis) is regulated by a major signaling pathway known as NF-kB. The researchers found that miR-181b is a potent regulator of this pathway within . miR-181b specifically targets importin-alpha3, a protein essential in NF-kB signaling.

Overexpression of miR-181b inhibited importin-alpha3 expression, as well as other molecules involved in the NF-kB signaling pathway; thereby, reducing the inflammation response.

The researchers discovered this after giving miR-181b intravenously in mice with sepsis. This led to increased survival and reduced inflammatory damage in the lungs of septic mice.

"We have discovered a microRNA that is important in dampening the inflammatory response and reducing tissue injury by targeting NF-kB in the lining of the blood , known as the vascular endothelium," said Feinberg. "The beneficial role of this microRNA in sepsis is likely the tip of the iceberg since excessive inflammation is a pervasive finding in a wide-range of acute and chronic diseases."

In the accompanying commentary, Drs. Jason Fish and Myron Cybulsky from the University of Toronto note that microRNAs, such as miR-181b, may be exciting and attractive targets for future vascular inflammatory disease therapeutics.

Related Stories

Key to out-of-control immune response in lung injury found

Aug 16, 2007

Researchers at the University of Illinois at Chicago College of Medicine have discovered how a protein modulates the inflammatory response in sudden, life-threatening lung failure. The protein's previously unknown role is ...

IADR/AADR publish study on obesity link to periodontitis

Oct 31, 2011

In a study titled "MicroRNA Modulation in Obesity and Periodontitis," lead author Romina Perri, University of North Carolina School of Dentistry, Oral Health Institute, conducted a pilot investigation to determine whether ...

Small molecules may explain psoriasis

Jul 11, 2007

A research team at the Swedish medical university Karolinska Institutet has shown for the time that microRNA, small RNA molecules, may play an important role in the development of inflammatory skin diseases such as psoriasis ...

Recommended for you

Brain neuroinflammation seen in chronic fatigue syndrome

Apr 11, 2014

(HealthDay)—Neuroinflammation markers are elevated in the brains of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) patients compared to healthy controls, according to a study published online ...

Which asthma drugs, dosages work best for African Americans?

Feb 19, 2014

The University of Illinois at Chicago has received funding from the National Institutes of Health to determine what combination and dosages of asthma medications works best to manage asthma in African Americans, who suffer ...

User comments